BabyBIG

STN: 125034
Proper Name: Botulism Immune Globulin Intravenous (Human)
Tradename: BabyBIG
Manufacturer: California Department of Public Health (CDPH)

Indication

• Treatment of infant botulism caused by toxin types A or B in patients below one year of age.  

Product Information

• Package Insert - BabyBIG

Supporting Documents

• June 23, 2021 Approval Letter - BabyBIG
• March 29, 2016 Approval Letter - BabyBIG
• Supporting Documents older than three years - BabyBIG

Related Information

• Dear Healthcare Provider Letter: IMPORTANT CHANGE IN BabyBIG PRESCRIBING INFORMATION - ARCHIVED
  Date: September 23, 2013